Vaccine Administration: The Growing Role of Prefilled Syringes
Pharmaceutical Technology Europe
; 34(8):19-21, 2022.
Article
Dans Anglais
| ProQuest Central | ID: covidwho-20242828
ABSTRACT
(Note The MIDAS database reflects vaccine doses that are dispensed with a prescription in retail or hospital settings, so the COVID-19 vaccines and other public-health-administered vaccines are not fully reflected in that data set.) Stamoran adds, "However, across the rest of the world, vial-based vaccines still make up the majority of the volume dispensed." [...]there is plenty of room for growth for this newer administration device. [...]PFS are now widely used for annual flu shots, heparin injections, and a growing list of injectable therapies across multiple disease states. According to a 2021 article authored byGuillaume Lehee, R&D Innovation Leader for BD Medical-Pharmaceutical Systems, the use of PFS to vaccinate 300 million individuals in the United States in the event of a future pandemic could save more than three million hours of healthcare practitioners' time (1). [...]today's PFS are not yet proven to be compatible with ultrafrozen temperatures as the existing glass materials and other components may not stand up to the extremely low required temperatures," explains Stamoran.
Pharmacy And Pharmacology; COVID-19 vaccines; Zika virus; Pharmacy; Regulatory approval; Influenza; Design; Manufacturers; Pharmaceutical industry; Manufacturing; Research & development--R&D; Coronaviruses; Immunization; Drug dosages; Tropical diseases; Disease transmission; United States--US; 32541:Pharmaceutical and Medicine Manufacturing
Collection:
Bases de données des oragnisations internationales
Base de données:
ProQuest Central
Les sujets:
Vaccins
langue:
Anglais
Revue:
Pharmaceutical Technology Europe
Année:
2022
Type de document:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS